MarketPeel
Pricing
…
President and CEO
David Alan Campbell
Wed, Jul 8, 2026
Jul 8
exercised or converted securities in
JANX
7,000
shares @ $0.00
Decreased holdings by
-1.00%
Net across this filing:
+1.80%
(+7,000 shares)
JANX
Janux Therapeutics, Inc.
Healthcare
Biotechnology
1D
0.00%
1W
+7.88%
1M
+13.44%
3M
—
6M
—
1Y
—
Recent insider activity at JANX
Jun 2
Janeen Noel Doyle
Sold
$56.94k
May 11
Maria Dobek
Sold
$28.88k
Jan 2
David Alan Campbell
Sold
$110.83k
Jan 2
Maria Dobek
Sold
$20.07k
Jan 2
Andrew Hollman Meyer
Sold
$25.80k
Jan 2
Thomas Diraimondo
Sold
$34.39k
Jan 2
Charles M. Winter
Sold
$32.97k
Jan 2
Zachariah Mciver
Sold
$37.26k
Full JANX profile →
David Alan Campbell’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback